The atopic dermatitis market

Nature Reviews Drug Discovery 17, 237 (2018). doi:10.1038/nrd.2017.192 Authors: Eleni Pantazi, Gianluca Valenza, Manuela Hess & Bashar Hamad The market for atopic dermatitis therapies is dominated by topical corticosteroids, but is poised to change with the recent approvals of dupilumab and crisaborole, as well as other drugs in clinical development.
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Tags: News and Analysis Source Type: research